{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:4171",
      "entity_text" : "metoprolol",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5324346",
      "entity_text" : "fluvoxamine",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "The first limitation is that they did not consider the weak CYP2D6 inhibitory capacity of citalopram as well as fluvoxamine in their analysis.9, 11, 26, 33, 34 Although citalopram is considered to be safely combined with metoprolol, it is still able to increase the AUC of metoprolol approximately 2 to 3 times.9, 33, 35 This weak inhibition may be important in the older people because of the age related physiological changes.",
  "reading_complete" : "2020-08-05T20:59:57Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T20:58:05Z",
  "trigger" : "increase",
  "evidence" : [ "fluvoxamine in their analysis.9, 11, 26, 33, 34 Although citalopram is considered to be safely combined with metoprolol, it is still able to increase the AUC of metoprolol" ],
  "pmc_id" : "6001522",
  "score" : 0
}